FDA Inspection 1081239 — Holy Cross of Silver Spring Blood Bank
The FDA completed an inspection of Holy Cross of Silver Spring Blood Bank on January 29, 2019 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 29, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Silver Spring, MD (United States)